Addiction

Project 55 Launches Free Mental Health First Responder Training for Public Use

Evidence-informed course equips non-professionals to respond to mental health crises with practical, scalable skills Project 55 Logo LADERA RANCH, Calif.,…

8 months ago

Adial Pharmaceuticals Advances Toward Phase 3 Development for AD04

Engages with Cytel’s Machine Learning Technology on Data Analysis and Phase 3 Trial DesignGLEN ALLEN, Va., June 11, 2025 (GLOBE…

8 months ago

BrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder (MDD)

Improvement in depression scores, response and remission were all found to be comparable with standard Deep TMS in non-inferiority trialBURLINGTON,…

8 months ago

Chestnut Health Systems Launches The Catalyst – A Podcast and Newsletter Advancing Recovery Science

BLOOMINGTON, Ill., June 10, 2025 /PRNewswire/ -- Chestnut Health Systems™ announced the launch of The Catalyst, a weekly podcast and…

8 months ago

BrainsWay Announces Gold Sponsorship at the 2025 Clinical TMS Society Annual Meeting in San Diego

Deep TMS Takes Center Stage with Compelling ResearchBURLINGTON, Mass. and JERUSALEM, June 10, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ…

8 months ago

Ambio Life Sciences Launches World’s First Clinical Ibogaine Program for Patients With Neurodegenerative Conditions

Facilities and care team tailored for patients with complex medical needs Specialized protocol includes optimized dosing and therapeutic support for…

8 months ago

BrainsWay Announces $5 Million Minority-Stake Investment in Stella MSO, LLC

BrainsWay is actively evaluating similar investments in other leading U.S. mental health providers to raise awareness and expand access to…

8 months ago

TOLREMO therapeutics Announces TT125-802 is the First CBP/p300 Bromodomain Inhibitor to Show Clinical Activity in Solid Tumors 

- Deep and durable responses in drug-resistant KRAS-G12C- and EGFR-mutant NSCLC - Best-in-class safety profile highlights potential for development in…

8 months ago

Nest Health Launches Home-Based Substance Use Disorder Program to Expand Access to Life-Saving Treatment

NEW ORLEANS, June 3, 2025 /PRNewswire/ -- Nest Health, the leading family-centered, home-based healthcare provider for high-risk families, today announced…

8 months ago

Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference

SEATTLE and VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage specialty…

8 months ago